NCT06931431 UNCPM 22322 - Adaption of the Transition of Care Model for Post-Discharge HIV-NCD Care in Lilongwe, Malawi - MLATHO
| NCT ID | NCT06931431 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Chapel Hill |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-05-12 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-05-12 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an implementation research study that will adapt and pilot test the Transitional Of Care Model (TCM), originally conceived and developed in the USA, for targeted use as a post-discharge intervention for adults hospitalized with comorbid HIV and NCDs in Malawi using a mixed methods approach.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * living with HIV * admitted to internal medicine * has at least a cardiometabolic NCO as the primary or secondary reason for admission based on the HIV inpatient consultation Exclusion Criteria: * patients living beyond Lilongwe urban
Contact & Investigator
Cecilia Kanyama, MBBS
PRINCIPAL INVESTIGATOR
University of North Carolina at Chapel Hill (Project Malawi)
Frequently Asked Questions
Who can join the NCT06931431 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06931431 currently recruiting?
Yes, NCT06931431 is actively recruiting participants. Contact the research team at cchawinga@unclilongwe.org.mw for enrollment information.
Where is the NCT06931431 trial being conducted?
This trial is being conducted at Lilongwe, Malawi.
Who is sponsoring the NCT06931431 clinical trial?
NCT06931431 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Cecilia Kanyama, MBBS at University of North Carolina at Chapel Hill (Project Malawi). The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.